ClinicalTrials.Veeva

Menu

Resting-state Imaging and OSteoporosiS (ROSS)

U

University Hospital, Clermont-Ferrand

Status

Not yet enrolling

Conditions

Osteoporosis

Treatments

Other: Functional connectivity value of brain networks at rest
Other: Bone density exam
Other: Blood sample
Other: Tests and questionnaires of study

Study type

Interventional

Funder types

Other

Identifiers

NCT07030205
2025-A00106-43 (Other Identifier)
RBHP 2025 PICKERING_ME

Details and patient eligibility

About

This study will be conducted in 20 postmenopausal healthy volunteers, 20 postmenopausal osteoporotic patients with fracture and 20 postmenopausal osteoporotic women without fracture, in order to compare functional connectivity between brain areas. Participants will complete different questionnaires and tests assessing cognition, quality of life, sleep, physical activity, pain, anxiety and depression. A biological sample will be performed in order to evaluate different markers of bone remodeling. A Resting-state functional magnetic resonance imaging (rs-fMRI) will be realized in order to establish functional connectivity between brain regions.

Enrollment

66 estimated patients

Sex

Female

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (patients):

  • Women aged 50 or over, with postmenopausal osteoporosis, fractured or not, diagnosed by their rheumatologist,
  • Able to give informed consent to participate in the research,
  • Affiliation with the French Social Security.

Inclusion Criteria (healthy volunteers):

  • Women aged 50 or over,
  • Bone densitometry performed as part of the protocol, not suggestive of osteoporosis and validated by investigators,
  • Matched to patients by age, menopausal status, socio-educational level and manual laterality,
  • Able to give informed consent to participate in the research,
  • Affiliation with the French Social Security.
  • Registration or acceptance of registration in the national register of volunteers participating in Research.

Exclusion Criteria (patient and healthy volunteers):

  • Presence of pacemaker,
  • Presence of medical devices (implants or prostheses),
  • Incompatibility of the patient with the safety criteria of the medical imaging center for carrying out magnetic resonance experiments at 3 Tesla,
  • Contraindications to the realization of MRI without injection such as claustrophobia proven, hearing aid, pacemaker wearers, wearing a brain clip,
  • Refusal to be informed in the event of the accidental discovery of an anomaly during the resting state functional magnetic resonance imaging,
  • Woman under legal protection or deprived of liberty,
  • Refusal to participation

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

66 participants in 3 patient groups

Postmenopausal Healthy volunteers
Experimental group
Description:
22 postmenopausal healthy women, matched by age, menopausal status, socio-educational level and manual laterality, will be included in this study
Treatment:
Other: Tests and questionnaires of study
Other: Blood sample
Other: Bone density exam
Other: Functional connectivity value of brain networks at rest
Postmenopausal osteoporotic patients with fracture
Experimental group
Description:
22 Postmenopausal osteoporosis patients with fractures will be included in this study
Treatment:
Other: Tests and questionnaires of study
Other: Blood sample
Other: Functional connectivity value of brain networks at rest
Postmenopausal osteoporotic patient without fracture
Experimental group
Description:
22 Postmenopausal osteoporosis patients without fractures will be included in this study.
Treatment:
Other: Tests and questionnaires of study
Other: Blood sample
Other: Functional connectivity value of brain networks at rest

Trial contacts and locations

1

Loading...

Central trial contact

Lise Laclautre

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems